- Home
- EVM vs SOPH Comparison
EVM vs SOPH Comparison
Compare EVM & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVM
- SOPH
- Stock Information
- Founded
- EVM 2002
- SOPH 2011
- Country
- EVM United States
- SOPH Switzerland
- Employees
- EVM N/A
- SOPH N/A
- Industry
- EVM Finance/Investors Services
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVM Finance
- SOPH Health Care
- Exchange
- EVM Nasdaq
- SOPH Nasdaq
- Market Cap
- EVM 219.2M
- SOPH 206.6M
- IPO Year
- EVM N/A
- SOPH 2021
- Fundamental
- Price
- EVM $9.02
- SOPH $2.93
- Analyst Decision
- EVM
- SOPH Strong Buy
- Analyst Count
- EVM 0
- SOPH 2
- Target Price
- EVM N/A
- SOPH $6.50
- AVG Volume (30 Days)
- EVM 55.8K
- SOPH 26.9K
- Earning Date
- EVM 01-01-0001
- SOPH 05-06-2025
- Dividend Yield
- EVM 4.01%
- SOPH N/A
- EPS Growth
- EVM N/A
- SOPH N/A
- EPS
- EVM 0.20
- SOPH N/A
- Revenue
- EVM N/A
- SOPH $67,173,000.00
- Revenue This Year
- EVM N/A
- SOPH $14.86
- Revenue Next Year
- EVM N/A
- SOPH $22.76
- P/E Ratio
- EVM $47.61
- SOPH N/A
- Revenue Growth
- EVM N/A
- SOPH 4.66
- 52 Week Low
- EVM $7.67
- SOPH $2.58
- 52 Week High
- EVM $9.59
- SOPH $6.28
- Technical
- Relative Strength Index (RSI)
- EVM 51.18
- SOPH 44.97
- Support Level
- EVM $8.89
- SOPH $2.90
- Resistance Level
- EVM $9.14
- SOPH $3.33
- Average True Range (ATR)
- EVM 0.13
- SOPH 0.21
- MACD
- EVM 0.04
- SOPH 0.00
- Stochastic Oscillator
- EVM 73.33
- SOPH 21.78
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.